WO2002038744A3 - Proteases - Google Patents
Proteases Download PDFInfo
- Publication number
- WO2002038744A3 WO2002038744A3 PCT/US2001/051034 US0151034W WO0238744A3 WO 2002038744 A3 WO2002038744 A3 WO 2002038744A3 US 0151034 W US0151034 W US 0151034W WO 0238744 A3 WO0238744 A3 WO 0238744A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prts
- provides
- proteases
- polynucleotides
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002542060A JP2004535153A (en) | 2000-10-18 | 2001-10-18 | Protease |
US10/399,645 US20040029249A1 (en) | 2001-10-18 | 2001-10-18 | Proteases |
EP01987550A EP1387886A2 (en) | 2000-10-18 | 2001-10-18 | Proteases |
CA002425829A CA2425829A1 (en) | 2000-10-18 | 2001-10-18 | Proteases |
AU2002239753A AU2002239753A1 (en) | 2000-10-18 | 2001-10-18 | Proteases |
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24157300P | 2000-10-18 | 2000-10-18 | |
US60/241,573 | 2000-10-18 | ||
US24364300P | 2000-10-25 | 2000-10-25 | |
US60/243,643 | 2000-10-25 | ||
US24525600P | 2000-11-02 | 2000-11-02 | |
US60/245,256 | 2000-11-02 | ||
US24839500P | 2000-11-13 | 2000-11-13 | |
US60/248,395 | 2000-11-13 | ||
US24982600P | 2000-11-16 | 2000-11-16 | |
US60/249,826 | 2000-11-16 | ||
US25230300P | 2000-11-20 | 2000-11-20 | |
US60/252,303 | 2000-11-20 | ||
US25098100P | 2000-12-01 | 2000-12-01 | |
US60/250,981 | 2000-12-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002038744A2 WO2002038744A2 (en) | 2002-05-16 |
WO2002038744A3 true WO2002038744A3 (en) | 2003-11-20 |
Family
ID=27569436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/051034 WO2002038744A2 (en) | 2000-10-18 | 2001-10-18 | Proteases |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1387886A2 (en) |
JP (1) | JP2004535153A (en) |
AU (1) | AU2002239753A1 (en) |
CA (1) | CA2425829A1 (en) |
WO (1) | WO2002038744A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030138925A1 (en) * | 2000-04-13 | 2003-07-24 | Tim Keith | Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
US6683165B1 (en) | 1999-04-13 | 2004-01-27 | Genome Therapeutics Corporation | Human gene relating to respiratory diseases and obesity |
WO2002066643A2 (en) * | 2000-11-13 | 2002-08-29 | Curagen Corporation | Proteins, polynucleotides encoding them and methods of using the same |
ES2280306T3 (en) * | 2000-12-25 | 2007-09-16 | Astellas Pharma Inc. | PROTEASA NOVEDOSA. |
AU2002243679A1 (en) * | 2001-01-24 | 2002-08-06 | Zymogenetics, Inc. | Cub domain protein zcub3 and materials and methods for making it |
WO2002088303A2 (en) * | 2001-04-03 | 2002-11-07 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel cysteine protease of the calpain superfamily, can-12, and variants thereof |
WO2003104394A2 (en) * | 2002-05-21 | 2003-12-18 | Dendreon San Diego Llc | Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon |
EP1544304A4 (en) * | 2002-07-31 | 2006-05-10 | Astellas Pharma Inc | Novel serine protease |
BRPI0922344A2 (en) * | 2008-12-19 | 2017-10-24 | 3B Pharmaceuticals Gmbh | tfpi inhibitors and methods of use |
WO2020260309A1 (en) | 2019-06-24 | 2020-12-30 | Urteste Sp. Z O.O. | Novel diagnostic marker for pancreatic cancer |
EP3845664A1 (en) * | 2020-01-02 | 2021-07-07 | Urteste Sp. z o.o. | Novel diagnostic marker for prostate cancer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994017820A1 (en) * | 1993-02-05 | 1994-08-18 | Daratech Pty. Ltd. | Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same |
WO1996013523A1 (en) * | 1994-10-27 | 1996-05-09 | Khepri Pharmaceuticals, Inc. | Cathepsin o2 protease |
-
2001
- 2001-10-18 EP EP01987550A patent/EP1387886A2/en not_active Withdrawn
- 2001-10-18 AU AU2002239753A patent/AU2002239753A1/en not_active Abandoned
- 2001-10-18 CA CA002425829A patent/CA2425829A1/en not_active Abandoned
- 2001-10-18 WO PCT/US2001/051034 patent/WO2002038744A2/en not_active Application Discontinuation
- 2001-10-18 JP JP2002542060A patent/JP2004535153A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994017820A1 (en) * | 1993-02-05 | 1994-08-18 | Daratech Pty. Ltd. | Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same |
WO1996013523A1 (en) * | 1994-10-27 | 1996-05-09 | Khepri Pharmaceuticals, Inc. | Cathepsin o2 protease |
Non-Patent Citations (5)
Title |
---|
DATABASE EMBL [online] 12 December 1992 (1992-12-12), XP002245648, Database accession no. L07772 * |
DATABASE EMBL [online] 20 February 1989 (1989-02-20), XP002245647, Database accession no. M20496 * |
DATABASE EMBL [online] 24 February 1989 (1989-02-24), XP002245646, Database accession no. X12451 * |
DATABASE SWISSPROT [online] 1 April 1988 (1988-04-01), XP002245645, Database accession no. P07711; Q96QJ0 * |
DATABASE WPI Section Ch Week 200158, Derwent World Patents Index; Class B04, AN 2001-524255, XP002245650 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002239753A1 (en) | 2002-05-21 |
JP2004535153A (en) | 2004-11-25 |
EP1387886A2 (en) | 2004-02-11 |
WO2002038744A2 (en) | 2002-05-16 |
CA2425829A1 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001098468A3 (en) | Proteases | |
WO2003052075A3 (en) | Enzymes | |
WO2002008396A3 (en) | Human proteases | |
WO2002063005A3 (en) | Lipid-associated molecules | |
WO2001096547A3 (en) | Human kinases | |
WO2001060991A3 (en) | Human kinases | |
WO2002018557A3 (en) | Human kinases | |
WO2002083709A3 (en) | Kinases and phosphatases | |
WO2001072777A3 (en) | Human transcription factors | |
WO2002038744A3 (en) | Proteases | |
WO2003042357A3 (en) | Enzymes | |
WO2001071004A3 (en) | Proteases | |
WO2001096546A3 (en) | Protein phosphatases | |
WO2002026950A3 (en) | Transferases | |
WO2002097060A3 (en) | Carbohydrate-associated proteins | |
WO2001085942A3 (en) | Cytoskeleton-associated proteins | |
WO2002010363A3 (en) | Protein phosphatases | |
WO2000042201A3 (en) | Human peptidases | |
WO2002020736A3 (en) | Proteases | |
WO2001046443A3 (en) | Proteases | |
WO2001081555A3 (en) | Human kinases | |
WO2002033099A3 (en) | Human kinases | |
WO2002024924A3 (en) | Protein phosphatases | |
WO2002066646A3 (en) | Neurotransmission-associated proteins | |
WO2002064795A3 (en) | Putative human enzymes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2425829 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002542060 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10399645 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001987550 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001987550 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001987550 Country of ref document: EP |